🔬Deep Research
SDGR — Schrödinger · catalysts, narrative & risks
Schrödinger, Inc. (SDGR) — Research Summary (as of November 6, 2026)
Background and current state
Schrödinger is a New York–based company (founded 1990) that develops a physics-based computational platform for molecular discovery in drug development and materials science, operating through two segments: Software and Drug Discovery [24] [28] [DOC-5]. It trades on Nasdaq under SDGR and is a component of both the Russell 2000 and the S&P 600 [23] [28].
AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →